Loading...
Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways
OBJECTIVE: Liver fibrosis is a consequence of wound-healing responses to chronic liver insult and may progress to liver cirrhosis if not controlled. This study investigated the protection against liver fibrosis by isorhamnetin. METHODS: Mouse models of hepatic fibrosis were established by intraperit...
Na minha lista:
| Udgivet i: | Mediators Inflamm |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6701280/ https://ncbi.nlm.nih.gov/pubmed/31467486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6175091 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|